株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

プロテインAレジンの世界市場 - ソース・成分マトリクス・用途・利用者別分析と産業の規模、シェアおよび成長予測:2030年まで

Protein A Resin Market Research Report: By Source, Matrix, Application, End User and Industry Size, Share, Trends and Forecast to 2030

発行 Prescient & Strategic Intelligence Private Limited 商品コード 930704
出版日 ページ情報 英文 184 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.54円で換算しております。
プロテインAレジンの世界市場 - ソース・成分マトリクス・用途・利用者別分析と産業の規模、シェアおよび成長予測:2030年まで Protein A Resin Market Research Report: By Source, Matrix, Application, End User and Industry Size, Share, Trends and Forecast to 2030
出版日: 2020年01月01日 ページ情報: 英文 184 Pages
概要

プロテインAレジン市場の主な推進要因には、人口老齢化、慢性疾患の広がり、タンパク質研究への資金提供、さまざまな条件に応じた治療法ニーズに対応する必要性などが挙げられます。その市場収益は2019年の4億8640万ドルから、分析対象とした2019-2030年の期間を通じて7.0%の年成長率で拡大し、2030年には10億207万ドルに急増する見込みです。プロテインAレジンは免疫沈降や色層分析(クロマトグラフィ)など精製プロセス時の分離媒体として使用される物質であり、酵素系生体混合物や抗原抗体、受容体・核酸インタラクションを分離する働きをします。

当レポートでは、プロテインAレジンの世界市場に注目し、2019-2030年の期間における取引規模をソース、成分マトリクス、用途、利用者、地域の別に試算するほか、参入企業間の競合状況など最新の調査情報を提供します。

第1章 調査の背景

  • 調査目的
  • 市場の定義
  • 調査範囲
    • ソース別市場区分
    • 成分マトリクス別市場区分
    • 用途別市場区分
    • 利用者別市場区分
    • 地域別市場区分
    • 分析対象期間
    • 市場データの表記単位
  • 主要ステークホルダー

第2章 調査方法

  • 二次調査
  • 一次調査
    • 一次情報提供者の内訳
  • 市場規模の試算
  • 三角法データ評価
  • 調査の前提

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 市場区分の定義
    • ソース別
    • 成分マトリクス別
    • 用途別
    • 利用者別
  • 市場動態
    • 潮流
    • 推進要因
    • 抑制要因
    • 発展機会
  • Porterのファイブフォース分析

第5章 世界市場の規模と予測

  • ソース別
  • 成分マトリクス別
  • 用途別
  • 利用者別
  • 地域別

第6章 北米の市場規模と予測

  • ソース別
  • 成分マトリクス別
  • 用途別
  • 利用者別
  • 国別
    • 米国
    • カナダ

第7章 欧州の市場規模と予測

  • ソース別
  • 成分マトリクス別
  • 用途別
  • 利用者別
  • 国別
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • スペイン

第8章 アジア太平洋州の市場規模と予測

  • ソース別
  • 成分マトリクス別
  • 用途別
  • 利用者別
  • 国別
    • 日本
    • 中国
    • インド

第9章 中南米の市場規模と予測

  • ソース別
  • 成分マトリクス別
  • 用途別
  • 利用者別
  • 国別

第10章 中東・アフリカ市場規模と予測

  • ソース別
  • 成分マトリクス別
  • 用途別
  • 利用者別
  • 国別

第11章 競合環境

  • 企業別シェア分析
  • 主要参入企業の製品ベンチマーキング
  • 主要企業の施策展開
    • 事業買収
    • 企業協力
    • その他の展開

第12章 企業プロファイル(事業概要、提供品目・サービス、主要収支サマリーなど)

  • Bio-Works Technologies AB
  • Amikozen Co. Ltd.
  • Bio-Rad Laboratories Inc.
  • Expedeon AG
  • Thermo Fisher Scientific Inc.
  • GenScript Biotech Corporation
  • Merck KGaA
  • 東ソー株式会社
  • Repligen Corporation
  • Novasep Holding SAS
  • Purolite Corporation
  • 株式会社カネカ
  • General Electric Company

第13章 付録

  • 略語
  • 出典と参考資料
  • 関連レポート
図表

List of Tables

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 NUMBER OF DEATHS DUE TO VARIOUS DISEASES WORLDWIDE
  • TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 5 GLOBAL PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 6 GLOBAL PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 7 GLOBAL PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 8 GLOBAL PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 9 GLOBAL PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 10 GLOBAL PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 11 GLOBAL PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 12 GLOBAL PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 13 GLOBAL PROTEIN A RESIN MARKET, BY REGION, $M (2014-2019)
  • TABLE 14 GLOBAL PROTEIN A RESIN MARKET, BY REGION, $M (2020-2030)
  • TABLE 15 NORTH AMERICA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 16 NORTH AMERICA PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 17 NORTH AMERICA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 18 NORTH AMERICA PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 19 NORTH AMERICA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 20 NORTH AMERICA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 21 NORTH AMERICA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 22 NORTH AMERICA PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 23 NORTH AMERICA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 24 NORTH AMERICA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 25 U.S. PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 26 U.S. PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 27 U.S. PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 28 U.S. PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 29 U.S. PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 30 U.S. PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 31 U.S. PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 32 U.S. PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 33 CANADA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 34 CANADA PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 35 CANADA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 36 CANADA PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 37 CANADA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 38 CANADA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 39 CANADA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 40 CANADA PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 41 EUROPE PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 42 EUROPE PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 43 EUROPE PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 44 EUROPE PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 45 EUROPE PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 46 EUROPE PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 47 EUROPE PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 48 EUROPE PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 49 EUROPE PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 50 EUROPE PROTEIN A RESIN MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 51 GERMANY PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 52 GERMANY PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 53 GERMANY PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 54 GERMANY PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 55 GERMANY PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 56 GERMANY PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 57 GERMANY PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 58 GERMANY PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 59 FRANCE PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 60 FRANCE PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 61 FRANCE PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 62 FRANCE PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 63 FRANCE PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 64 FRANCE PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 65 FRANCE PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 66 FRANCE PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 67 ITALY PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 68 ITALY PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 69 ITALY PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 70 ITALY PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 71 ITALY PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 72 ITALY PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 73 ITALY PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 74 ITALY PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 75 U.K. PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 76 U.K. PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 77 U.K. PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 78 U.K. PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 79 U.K. PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 80 U.K. PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 81 U.K. PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 82 U.K. PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 83 SPAIN PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 84 SPAIN PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 85 SPAIN PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 86 SPAIN PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 87 SPAIN PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 88 SPAIN PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 89 SPAIN PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 90 SPAIN PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 91 APAC PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 92 APAC PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 93 APAC PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 94 APAC PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 95 APAC PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 96 APAC PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 97 APAC PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 98 APAC PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 99 APAC PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 100 APAC PROTEIN A RESIN MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 101 JAPAN PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 102 JAPAN PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 103 JAPAN PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 104 JAPAN PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 105 JAPAN PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 106 JAPAN PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 107 JAPAN PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 108 JAPAN PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 109 CHINA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 110 CHINA PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 111 CHINA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 112 CHINA PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 113 CHINA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 114 CHINA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 115 CHINA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 116 CHINA PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 117 INDIA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 118 INDIA PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 119 INDIA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 120 INDIA PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 121 INDIA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 122 INDIA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 123 INDIA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 124 INDIA PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 125 LATAM PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 126 LATAM PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 127 LATAM PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 128 LATAM PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 129 LATAM PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 130 LATAM PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 131 LATAM PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 132 LATAM PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 133 LATAM PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 134 LATAM PROTEIN A RESIN MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 135 MEA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 136 MEA PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 137 MEA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 138 MEA PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 139 MEA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 140 MEA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 141 MEA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 142 MEA PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 143 MEA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 144 MEA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 145 BIO-WORKS TECHNOLOGIES AB - AT A GLANCE
  • TABLE 146 BIO-WORKS TECHNOLOGIES AB - KEY FINANCIAL SUMMARY
  • TABLE 147 AMIKOZEN CO. LTD. - AT A GLANCE
  • TABLE 148 BIO-RAD LABORATORIES INC - AT A GLANCE
  • TABLE 149 BIO-RAD LABORATORIES INC - KEY FINANCIAL SUMMARY
  • TABLE 150 EXPEDEON AG - AT A GLANCE
  • TABLE 151 EXPEDEON AG - KEY FINANCIAL SUMMARY
  • TABLE 152 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
  • TABLE 153 THERMO FISHER SCIENTIFIC INC. - KEY FINANCIAL SUMMARY
  • TABLE 154 GENSCRIPT BIOTECH CORPORATION - AT A GLANCE
  • TABLE 155 GENSCRIPT BIOTECH CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 156 MERCK KGAA - AT A GLANCE
  • TABLE 157 MERCK KGAA - KEY FINANCIAL SUMMARY
  • TABLE 158 TOSOH CORPORATION - AT A GLANCE
  • TABLE 159 TOSOH CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 160 REPLIGEN CORPORATION - AT A GLANCE
  • TABLE 161 REPLIGEN CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 162 NOVASEP HOLDING SAS - AT A GLANCE
  • TABLE 163 PUROLITE CORPORATION - AT A GLANCE
  • TABLE 164 KANEKA CORPORATION - AT A GLANCE
  • TABLE 165 KANEKA CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 166 GENERAL ELECTRIC COMPANY - AT A GLANCE
  • TABLE 167 GENERAL ELECTRIC COMPANY - KEY FINANCIAL SUMMARY

List of Figures

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 GLOBAL PROTEIN A RESIN MARKET SUMMARY
  • FIG 9 PERCENTAGE SHARE OF ELDERLY PEOPLE IN TOTAL POPULATION
  • FIG 10 BARGAINING POWER OF BUYERS
  • FIG 11 BARGAINING POWER OF SUPPLIERS
  • FIG 12 INTENSITY OF RIVALRY
  • FIG 13 THREAT OF NEW ENTRANTS
  • FIG 14 THREAT OF SUBSTITUTES
  • FIG 15 SNAPSHOT OF GLOBAL PROTEIN A RESIN MARKET
  • FIG 16 GLOBAL PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 17 GLOBAL PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 18 GLOBAL PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 19 GLOBAL PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 20 GLOBAL PROTEIN A RESIN MARKET, BY REGION, $M (2014-2030)
  • FIG 21 NORTH AMERICA PROTEIN A RESIN MARKET SNAPSHOT
  • FIG 22 NORTH AMERICA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 23 NORTH AMERICA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 24 NORTH AMERICA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 25 NORTH AMERICA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 26 NORTH AMERICA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 27 EUROPE PROTEIN A RESIN MARKET SNAPSHOT
  • FIG 28 EUROPE PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 29 EUROPE PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 30 EUROPE PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 31 EUROPE PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 32 EUROPE PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 33 APAC PROTEIN A RESIN MARKET SNAPSHOT
  • FIG 34 APAC PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 35 APAC PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 36 APAC PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 37 APAC PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 38 APAC PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 39 LATAM PROTEIN A RESIN MARKET SNAPSHOT
  • FIG 40 LATAM PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 41 LATAM PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 42 LATAM PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 43 LATAM PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 44 LATAM PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 45 MEA PROTEIN A RESIN MARKET SNAPSHOT
  • FIG 46 MEA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 47 MEA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 48 MEA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 49 MEA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 50 MEA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 51 PRODUCT BENCHMARKING OF KEY PLAYERS
  • FIG 52 BIO-WORKS TECHNOLOGIES AB - REVENUE SPLIT BY GEOGRAPHY (2018)
  • FIG 53 BIO-RAD LABORATORIES INC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 54 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 55 GENESCRIPT BIOTECH CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)
  • FIG 56 MERCK KGAA - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 57 TOSOH CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 58 REPLIGEN CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 59 KANEKA CORPORATION - REVENUE SPLIT BY SEGMENT (2018)
  • FIG 60 GENERAL ELECTRIC COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
目次

The major protein A resin market drivers are the increasing geriatric population, prevalence of chronic diseases, funding for protein research, and need to meet the need for therapies for various conditions. The market revenue is projected to surge to $1,020.7 million by 2030, from $486.4 million in 2019, at a 7.0% CAGR during the forecast period (2019-2030). Protein A resin is used as a separation medium during purification processes, such immunoprecipitation and chromatography. It separates biochemical mixtures based on the enzyme-substrate, antigen-antibody, and receptor-nucleic acid interactions.

Based on source, the protein A resin market is bifurcated into natural and recombinant, of which the recombinant bifurcation would display the higher CAGR, of 7.5%, during the forecast period. This is because recombinant protein A resins are heavily used during the production of monoclonal antibodies (mAb). Earlier, pharmaceutical companies did not pursue mAbs, owing to their stability, size, degradation rate, and delivery limitations. But, with increasing funding and focus of private and public institutions on protein-based research, the development of mAbs is picking up pace.

Across the world, the need for effective treatments for metabolic diseases, cardiovascular diseases, infectious diseases, and cancer is highly unmet. This is promoting the development of monoclonal antibodies, as they can function similar to the mediators involved in pathological processes. Additionally, mAbs and other therapeutic proteins are less toxic, highly effective and potent, safe, tolerable, selective, and chemically and biologically diverse, and they also do not accumulate much on tissues. Therefore, with the increase in the research and development (R&D) for mAbs, the usage of protein A resin would rise.

The application segment of the market also has two bifurcations - antibody purification and immunoprecipitation - of which antibody purification held the larger share in 2019 and it would also grow faster during the forecast period, at a 7.2% CAGR. Similarly, of the two bifurcations within the end user segment - academic institutes & research laboratories and biotechnology & pharmaceutical industries - the latter dominated the protein A resin market in 2019, with a 91.6% value share. This end user consumes the biomaterial in huge amounts to produce mAbs.

One of the primary reasons behind the rising demand for monoclonal antibodies is the increasing incidence of chronic diseases. mAbs display a suitable pharmacokinetic profile, their solubility can be customized, and they also have a lesser chance of inducing an immune response, which is essential for the treatment to work. The diseases caused by hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human papillomavirus (HPV) are increasing in prevalence, due to the low accessibility of healthcare in developing nations.

As per the Joint United Nations Program on HIV and AIDS (UNAIDS), 36.9 million had HIV in 2017. Similarly, as per the data jointly published by the American Stroke Association (ASA) and American Heart Association (AHA), heart diseases killed 836,546 people in the U.S. in 2018. Further, the World Health Organization (WHO) estimates the number of cancer cases, expected to be diagnosed in 2030, at 21.4 million. Thus, the rising prevalence of such diseases will lead to a surging demand for mAbs, thereby driving the protein A resin market advance.

Geographically, North America led the market in 2019, with a share of 37.4%, owing to the increasing requirement for protein therapeutics for chronic diseases and rising number of biopharmaceuticals with the Food and Drug Administration's approval. During the forecast period, Asia-Pacific (APAC) would observe the fastest progress in the protein A resin market during the forecast period, at a 7.8% CAGR. This would be because of the rising usage of such biomaterial in drug research, technological advancements, growing pharmaceutical sector, and surging demand for vaccines and other therapeutics.

Therefore, with the increasing R&D for drugs and disease treatment, especially for monoclonal antibodies, the consumption of protein A resin would also escalate.

TABLE OF CONTENTS

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Source
    • 1.3.2 Market Segmentation by Matrix
    • 1.3.3 Market Segmentation by Application
    • 1.3.4 Market Segmentation by End User
    • 1.3.5 Market Segmentation by Geography
    • 1.3.6 Analysis Period
    • 1.3.7 Market Data Reporting Unit
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Source
      • 4.1.1.1 Recombinant
      • 4.1.1.2 Natural
    • 4.1.2 By Matrix
      • 4.1.2.1 Agarose-based protein A
      • 4.1.2.2 Glass or silica-based protein A
      • 4.1.2.3 Organic polymer-based protein A
      • 4.1.2.4 Others
    • 4.1.3 By Application
      • 4.1.3.1 Antibody purification
      • 4.1.3.2 Immunoprecipitation
    • 4.1.4 By End User
      • 4.1.4.1 Biotechnology and pharmaceutical industries
      • 4.1.4.2 Academic institutes and research laboratories
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing number of collaborations and agreements
      • 4.2.1.2 Evolution of the market with product launches
    • 4.2.2 Drivers
      • 4.2.2.1 Increasing research activities to address unmet medical needs in various therapeutic areas
      • 4.2.2.2 Surging burden of chronic diseases
      • 4.2.2.3 Rising investment and funding for protein-based research
      • 4.2.2.4 Growing geriatric population
      • 4.2.2.5 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 Lack of updated regulatory standards
      • 4.2.3.2 Contamination issues during protein A synthesis and high capital requirements for drug development
      • 4.2.3.3 Complex nature of protein A chromatography process
      • 4.2.3.4 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Emerging markets in the APAC region
  • 4.3 Porter's Five Forces Analysis

Chapter 5. Global Market Size and Forecast

  • 5.1 By Source
  • 5.2 By Matrix
  • 5.3 By Application
  • 5.4 By End User
  • 5.5 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Source
  • 6.2 By Matrix
  • 6.3 By Application
  • 6.4 By End User
  • 6.5 By Country
    • 6.5.1 U.S. Market Size and Forecast
      • 6.5.1.1 By source
      • 6.5.1.2 By matrix
      • 6.5.1.3 By application
      • 6.5.1.4 By end user
    • 6.5.2 Canada Market Size and Forecast
      • 6.5.2.1 By source
      • 6.5.2.2 By matrix
      • 6.5.2.3 By application
      • 6.5.2.4 By end user

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Source
  • 7.2 By Matrix
  • 7.3 By Application
  • 7.4 By End User
  • 7.5 By Country
    • 7.5.1 Germany Market Size and Forecast
      • 7.5.1.1 By source
      • 7.5.1.2 By matrix
      • 7.5.1.3 By application
      • 7.5.1.4 By end user
    • 7.5.2 France Market Size and Forecast
      • 7.5.2.1 By source
      • 7.5.2.2 By matrix
      • 7.5.2.3 By application
      • 7.5.2.4 By end user
    • 7.5.3 Italy Market Size and Forecast
      • 7.5.3.1 By source
      • 7.5.3.2 By matrix
      • 7.5.3.3 By application
      • 7.5.3.4 By end user
    • 7.5.4 U.K. Market Size and Forecast
      • 7.5.4.1 By source
      • 7.5.4.2 By matrix
      • 7.5.4.3 By application
      • 7.5.4.4 By end user
    • 7.5.5 Spain Market Size and Forecast
      • 7.5.5.1 By source
      • 7.5.5.2 By matrix
      • 7.5.5.3 By application
      • 7.5.5.4 By end user

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Source
  • 8.2 By Matrix
  • 8.3 By Application
  • 8.4 By End User
  • 8.5 By Country
    • 8.5.1 Japan Market Size and Forecast
      • 8.5.1.1 By source
      • 8.5.1.2 By matrix
      • 8.5.1.3 By application
      • 8.5.1.4 By end user
    • 8.5.2 China Market Size and Forecast
      • 8.5.2.1 By source
      • 8.5.2.2 By matrix
      • 8.5.2.3 By application
      • 8.5.2.4 By end user
    • 8.5.3 India Market Size and Forecast
      • 8.5.3.1 By source
      • 8.5.3.2 By matrix
      • 8.5.3.3 By application
      • 8.5.3.4 By end user

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Source
  • 9.2 By Matrix
  • 9.3 By Application
  • 9.4 By End User
  • 9.5 By Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Source
  • 10.2 By Matrix
  • 10.3 By Application
  • 10.4 By End User
  • 10.5 By Country

Chapter 11. Competitive Landscape

  • 11.1 Company Share Analysis
  • 11.2 Product Benchmarking of Key Players
  • 11.3 Strategic Developments of Key Players
    • 11.3.1 Acquisitions
    • 11.3.2 Collaboration
    • 11.3.3 Other Developments

Chapter 12. Company Profiles

  • 12.1 Bio-Works Technologies AB
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
  • 12.2 Amikozen Co. Ltd.
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
  • 12.3 Bio-Rad Laboratories Inc.
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
    • 12.3.3 Key Financial Summary
  • 12.4 Expedeon AG
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
    • 12.4.3 Key Financial Summary
  • 12.5 Thermo Fisher Scientific Inc.
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
    • 12.5.3 Key Financial Summary
  • 12.6 GenScript Biotech Corporation
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
    • 12.6.3 Key Financial Summary
  • 12.7 Merck KGaA
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
    • 12.7.3 Key Financial Summary
  • 12.8 Tosoh Corporation
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
    • 12.8.3 Key Financial Summary
  • 12.9 Repligen Corporation
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
    • 12.9.3 Key Financial Summary
  • 12.10 Novasep Holding SAS
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
  • 12.11 Purolite Corporation
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
  • 12.12 Kaneka Corporation
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
    • 12.12.3 Key Financial Summary
  • 12.13 General Electric Company
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
    • 12.13.3 Key Financial Summary

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports